These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1786200)

  • 1. The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophages.
    Baba N; Kawami H; Sato Y; Takayama T; Toge T
    Biotherapy; 1991; 3(4):359-64. PubMed ID: 1786200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSK and OK-432-induced immunomodulation of inducible nitric oxide (NO) synthase gene expression in mouse peritoneal polymorphonuclear leukocytes and NO-mediated cytotoxicity.
    Asai K; Kato H; Hirose K; Akaogi K; Kimura S; Mukai S; Inoue M; Yamamura Y; Sano H; Sugino S; Yoshikawa T; Kondo M
    Immunopharmacol Immunotoxicol; 2000 May; 22(2):221-35. PubMed ID: 10952028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of gene expression for nitric oxide synthase by immunomodulating drugs in the RAW264.7 murine macrophage cell line.
    Asai K; Kato H; Kimura S; Mukai S; Kawahito Y; Sano H; Kondo M; Akaogi K; Hirose K
    Cancer Immunol Immunother; 1996 Jun; 42(5):275-9. PubMed ID: 8706048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective activity of immunostimulants against Listeria monocytogenes infection in mice.
    Tomioka H; Sato K; Saito H
    J Med Microbiol; 1992 Feb; 36(2):112-6. PubMed ID: 1740781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunostimulants and antitumor agents on tumor necrosis factor (TNF) production.
    Mori H; Mihara M; Teshima K; Uesugi U; Xu Q; Sakamoto O; Koda A
    Int J Immunopharmacol; 1987; 9(8):881-92. PubMed ID: 2448255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the presence of intracellular OK-432 and antitumor activity of peritoneal macrophages.
    Toge T; Hamamoto S; Aratani K; Yamada H; Fujita T; Hattori T
    Int J Immunopharmacol; 1986; 8(6):599-603. PubMed ID: 3793325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK (review).
    Sakagami H; Aoki T; Simpson A; Tanuma S
    Anticancer Res; 1991; 11(2):993-9. PubMed ID: 2064356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of radiation and immunomodulators in the treatment of MM46 tumor transplanted in C3H/He mice.
    Miyaji C; Ogawa Y; Imajo Y; Imanaka K; Kimura S
    Oncology; 1983; 40(2):115-9. PubMed ID: 6828288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor].
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3453-60. PubMed ID: 3789756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
    Immunopharmacology; 1986 Apr; 11(2):79-86. PubMed ID: 3710767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432.
    Kawaguchi T; Suematsu M; Koizumi HM; Mitsui H; Suzuki S; Matsuno T; Ogawa H; Nomoto K
    Immunopharmacology; 1983 Oct; 6(3):177-89. PubMed ID: 6629737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synergistic activation of rat alveolar macrophages by cepharanthine and OK-432].
    Morioka S; Ono M; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1470-5. PubMed ID: 4015121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Competitive effect of PSK against the immunosuppressive effect induced in the sera of mice bearing syngeneic tumors].
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3461-7. PubMed ID: 3789757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopotentiating action of streptococcal preparation OK-432 and protein-bound polysaccharide PS-K on depressed state of cell-mediated and humoral immunities of Friend leukemia virus infected mice.
    Kiyohashi A
    Nihon Gan Chiryo Gakkai Shi; 1981 Aug; 16(4):641-6. PubMed ID: 7328350
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of OK-432 (picibanil) on the estrogen receptors of MCF-7 cells and potentiation of antiproliferative effects of tamoxifen in combination with OK-432.
    Aoyagi H; Iino Y; Takeo T; Horii Y; Morishita Y; Horiuchi R
    Oncology; 1997; 54(5):414-23. PubMed ID: 9260604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
    Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of activated macrophages to tumor cells through a macrophage lectin and its role in macrophage tumoricidal activity.
    Oda S; Sato M; Toyoshima S; Osawa T
    J Biochem; 1989 Jun; 105(6):1040-3. PubMed ID: 2768210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and augmentation of guinea pig macrophages with streptococcal preparation OK-432 and stimulated spleen cell products.
    Onozaki K; Suzuki K; Fukutomi Y; Yagami K; Hashimoto T
    J Reticuloendothel Soc; 1982 Dec; 32(6):433-42. PubMed ID: 6761439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of macrophage tumoricidal activity by a serum glycoprotein that increased in OK-432-treated mice.
    Torikai T; Itoh O; Satoh M; Osawa T
    Gan; 1980 Feb; 71(1):52-9. PubMed ID: 7380137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.